BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27330811)

  • 1. Phenotypic and functional testing of circulating regulatory T cells in advanced melanoma patients treated with neoadjuvant ipilimumab.
    Retseck J; VanderWeele R; Lin HM; Lin Y; Butterfield LH; Tarhini AA
    J Immunother Cancer; 2016; 4():38. PubMed ID: 27330811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long term impact of CTLA4 blockade immunotherapy on regulatory and effector immune responses in patients with melanoma.
    Retseck J; Nasr A; Lin Y; Lin H; Mendiratta P; Butterfield LH; Tarhini AA
    J Transl Med; 2018 Jul; 16(1):184. PubMed ID: 29973204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanoma antigen-specific effector T cell cytokine secretion patterns in patients treated with ipilimumab.
    Najjar YG; Ding F; Lin Y; VanderWeele R; Butterfield LH; Tarhini AA
    J Transl Med; 2017 Feb; 15(1):39. PubMed ID: 28222797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune monitoring of the circulation and the tumor microenvironment in patients with regionally advanced melanoma receiving neoadjuvant ipilimumab.
    Tarhini AA; Edington H; Butterfield LH; Lin Y; Shuai Y; Tawbi H; Sander C; Yin Y; Holtzman M; Johnson J; Rao UN; Kirkwood JM
    PLoS One; 2014; 9(2):e87705. PubMed ID: 24498358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline circulating IL-17 predicts toxicity while TGF-β1 and IL-10 are prognostic of relapse in ipilimumab neoadjuvant therapy of melanoma.
    Tarhini AA; Zahoor H; Lin Y; Malhotra U; Sander C; Butterfield LH; Kirkwood JM
    J Immunother Cancer; 2015; 3():39. PubMed ID: 26380086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.
    Strauss L; Bergmann C; Szczepanski M; Gooding W; Johnson JT; Whiteside TL
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4345-54. PubMed ID: 17671115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex-vivo expanded baboon CD4+ CD25 Hi Treg cells suppress baboon anti-pig T and B cell immune response.
    Singh AK; Seavey CN; Horvath KA; Mohiuddin MM
    Xenotransplantation; 2012; 19(2):102-11. PubMed ID: 22497512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional and phenotypic characteristics of CD4+CD25highFoxp3+ Treg clones obtained from peripheral blood of patients with cancer.
    Strauss L; Bergmann C; Whiteside TL
    Int J Cancer; 2007 Dec; 121(11):2473-83. PubMed ID: 17691114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional defect of circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in remission.
    Abdulahad WH; Stegeman CA; van der Geld YM; Doornbos-van der Meer B; Limburg PC; Kallenberg CG
    Arthritis Rheum; 2007 Jun; 56(6):2080-91. PubMed ID: 17530650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro induction of functional allergen-specific CD4+ CD25high Treg cells in horses affected with insect bite hypersensitivity.
    Hamza E; Akdis CA; Wagner B; Steinbach F; Marti E
    Clin Exp Allergy; 2013 Aug; 43(8):889-901. PubMed ID: 23889243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decrease of CD4(+) CD25(+) CD127(low) FoxP3(+) regulatory T cells with impaired suppressive function in untreated ulcerative colitis patients.
    Mohammadnia-Afrouzi M; Zavaran Hosseini A; Khalili A; Abediankenari S; Hosseini V; Maleki I
    Autoimmunity; 2015; 48(8):556-61. PubMed ID: 26333292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The subpopulation CD4(+); CD25(+); Foxp3(+);/CD127(low/-); regulatory T cells in peripheral blood of HIV-infected patients correlated with disease progression].
    Chen YL; Chen XR; Qin LX; Yang YF; Tang YM
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Nov; 28(11):1188-91. PubMed ID: 23127412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local and distant immunity induced by intralesional vaccination with an oncolytic herpes virus encoding GM-CSF in patients with stage IIIc and IV melanoma.
    Kaufman HL; Kim DW; DeRaffele G; Mitcham J; Coffin RS; Kim-Schulze S
    Ann Surg Oncol; 2010 Mar; 17(3):718-30. PubMed ID: 19915919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretransplant Recipient Circulating CD4+CD127lo/- Tumor Necrosis Factor Receptor 2+ Regulatory T Cells: A Surrogate of Regulatory T Cell-Suppressive Function and Predictor of Delayed and Slow Graft Function After Kidney Transplantation.
    Nguyen MT; Fryml E; Sahakian SK; Liu S; Cantarovich M; Lipman M; Tchervenkov JI; Paraskevas S
    Transplantation; 2016 Feb; 100(2):314-24. PubMed ID: 26425877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Children with egg allergy have evidence of reduced neonatal CD4(+)CD25(+)CD127(lo/-) regulatory T cell function.
    Smith M; Tourigny MR; Noakes P; Thornton CA; Tulic MK; Prescott SL
    J Allergy Clin Immunol; 2008 Jun; 121(6):1460-6, 1466.e1-7. PubMed ID: 18455222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reciprocal granzyme/perforin-mediated death of human regulatory and responder T cells is regulated by interleukin-2 (IL-2).
    Czystowska M; Strauss L; Bergmann C; Szajnik M; Rabinowich H; Whiteside TL
    J Mol Med (Berl); 2010 Jun; 88(6):577-88. PubMed ID: 20225066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency, suppressive capacity, recruitment and induction mechanisms of regulatory T cells in sinonasal squamous cell carcinoma and nasal inverted papilloma.
    Lou H; Fang J; Li P; Zhou W; Wang Y; Fan E; Li Y; Wang H; Liu Z; Xiao L; Wang C; Zhang L
    PLoS One; 2015; 10(5):e0126463. PubMed ID: 26020249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levels of circulating regulatory CD4+CD25+ T cells are decreased in breast cancer patients after vaccination with a HER2/neu peptide (E75) and GM-CSF vaccine.
    Hueman MT; Stojadinovic A; Storrer CE; Foley RJ; Gurney JM; Shriver CD; Ponniah S; Peoples GE
    Breast Cancer Res Treat; 2006 Jul; 98(1):17-29. PubMed ID: 16758122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.
    Fu J; Xu D; Liu Z; Shi M; Zhao P; Fu B; Zhang Z; Yang H; Zhang H; Zhou C; Yao J; Jin L; Wang H; Yang Y; Fu YX; Wang FS
    Gastroenterology; 2007 Jun; 132(7):2328-39. PubMed ID: 17570208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the induction of induced human CD4(+) CD25(+) FoxP3(+) T-regulatory cells and CD3(+) CD8(+) CD28(-) T-suppressor cells subset phenotypes in vitro: comparison of phorbol 12-myristate 13-acetate/ionomycin and phytohemagglutinin stimulation.
    Wang H; Daniel V; Sadeghi M; Opelz G
    Transplant Proc; 2013 Jun; 45(5):1822-31. PubMed ID: 23769052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.